Administrative Supplements for Development of Risk-Stratified Cancer Survivorship Care Algorithms NOT-CA-20-038 Division of Cancer Control and Population Sciences April 7, 2020
Using WebEx and Webinar Training Logistics ▪ All lines will be in listen-only mode ▪ Submit questions at any time during the presentation. Type into the Q&A Panel and select Host ▪ A moderator will ask the question on your behalf during the Q&A portions of the training ▪ This training webinar is being recorded and will be posted at a later date 2
Webinar presenters Michelle Mollica, PhD, Lisa Gallicchio, PhD MPH, RN, OCN Program Director, Program Director, Epidemiology and Healthcare Delivery Genomics Research Research Program Program 3
1. Background 2. Supplement notice details 3. Questions ▪ Note: questions about specific projects will not be addressed ▪ Note: questions about COVID-19 supplements will not be addressed. Please see: https://grants.nih.gov/policy/natural- disasters/corona-virus.htm 4
Background 5
Cancer Survivors: Estimated prevalence from 1975 to 2040 by age (in millions) 30 2040, 26.1M 25 20 2016, Millions 85+ 15.5 M 15 75-84 65-74 10 50-64 1975, < 50 3.6 M 5 0 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 2040 Source: Bluethmann, Mariotto & Rowland, CEBP 2016
Survivorship Care After Active Treatment Surveillance/ Prevention/ Health management of surveillance of promotion/ effects of cancer recurrence and preventive care and its new cancers treatment 7 Institute of Medicine. From cancer patient to cancer survivor: Lost in transition. Washington, DC: Institute of Medicine; 2005.
Risk-stratified Survivorship Care ▪ Follow-up care pathways for survivors tailored based on risk for specific factors, including symptom burden, recurrence, subsequent malignancies, functional impairments Shorter-term transition Low Risk to non-oncology providers Intermediate transition Moderate to non-oncology Risk providers Long-term follow-up High Risk led mostly by oncology specialists 8
Supplement Notice Details 9
Administrative Supplements for Development of Risk- Stratified Cancer Survivorship Care Algorithms ▪ Goal: to stimulate research focused on the development and/or validation of risk-stratification algorithms that categorize survivors into meaningful risk-stratified groups to inform appropriate follow-up care ▪ NCI is seeking supplement applications that propose methodological approaches to identify individuals within each group NOT-CA-20-038 Receipt date: May 15, 2020 10
Eligibility ▪ Administrative supplement applications are limited to current NCI- funded projects ▪ Applicants must hold an active eligible grant (R01, U01, R37, P01, U19, UM1) ▪ Supplements must support work within the scope of the parent award ▪ Can confirm this with your Program Director ▪ Please see NOT-CA-20-038 for details on application process 11
Important Considerations ▪ Applicants should utilize existing parent study data alone or in conjunction with data from other sources (e.g., electronic medical records, cancer registry, and/or claims data) ▪ Supplement is focused on adult cancer survivors, including adult survivors of childhood cancers ▪ Applicants may propose a single or multiple cancer types ▪ If focusing on one cancer type, application should address how this approach may serve as prototype for other cancers 12
Budget ▪ Budgets should not exceed more than $150,000 in total costs ▪ Supplement project must be within the currently approved project period for the existing parent award ▪ Requests for no-cost extensions to accommodate a supplement will not be permitted 13
Review process ▪ NCI will conduct reviews of submitted applications and will consider: ▪ Scientific merit of the proposed study ▪ Innovation of the proposed study ▪ Potential of the project to develop and/or validate a risk stratified algorithm ▪ Potential of developed algorithm to be utilized to inform care pathways for survivorship care 14
Tips for Applicants ▪ Review NOT-CA-20-038 carefully for instructions ▪ Application Due Date: May 15, 2020 ▪ Webinar and FAQ will be posted on our website: https://healthcaredelivery.cancer.gov/media ▪ Connect with us early Michelle Mollica, PhD, MPH, RN, OCN Email: michelle.mollica@nih.gov Lisa Gallicchio, PhD Email: Lisa.gallicchio@nih.gov 15
Questions? Please type your questions in the Q & A section on WebEx Stay connected with us! Subscribe to our email listserv using the link on our homepage: healthcaredelivery.cancer.gov epi.grants.cancer.gov Follow us on Twitter: @NCICareDelivRes and @NCIEpi 16
www.cancer.gov www.cancer.gov/espanol
Recommend
More recommend
